ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages
This article has 3 authors:Reviewed by ScreenIT
-
Potential applications of the rapid COVID-19 antibody test kit screening in comparison to the RT-PCR in patients and personnel at the Department of Obstetrics and Gynecology
This article has 6 authors:Reviewed by ScreenIT
-
COVID-19 Vaccination and Mental Health: A Difference-In-Difference Analysis of the Understanding America Study
This article has 5 authors:Reviewed by ScreenIT
-
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization
This article has 5 authors:Reviewed by ScreenIT
-
Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccination
This article has 11 authors:Reviewed by ScreenIT
-
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
This article has 19 authors:Reviewed by ScreenIT
-
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients
This article has 15 authors:Reviewed by ScreenIT
-
Present knowledge, attitude, practice, and fear level of Bangladeshi people towards covid-19 after a year of the pandemic situation: a web-based cross-sectional study
This article has 5 authors:Reviewed by ScreenIT
-
Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults
This article has 14 authors:Reviewed by ScreenIT
-
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
This article has 12 authors:Reviewed by ScreenIT